Downtown Boston’s 99 High St. Sells for $227M
Synergy Investments is the new owner of 99 High St., a prominent office building seen as a key indicator of where downtown office building values are headed.
Biopharma Firm Triples Footprint in Downtown Boston
by Steve Adams | May 30, 2023
A clinical-stage biopharma company that’s preparing to seek FDA approval for a schizophrenia treatment is tripling its footprint in a downtown Boston tower.
Most Popular | Most Recent
- High-Value AI Startup Leases Offices at One Lincoln
- River Run Bancorp Promotes New CFO
- Cape & Coast Bank Adds Trio of Executives
- Trial Court Offices Moving to Financial District
- Massachusetts Nearing 100 ‘Housing Choice’ Communities
- Personnel File – No. 438
- 163K SF Development Possible at Site of Cambridge Condos
- New Hampshire’s Top Lenders of 2025, Ranked
- Riverview’s Demise Highlights Condo Hazards
- How the Private Listings Race Will Hit Mass. Real Estate
- New England Development Redesigns Bunker Hill Mall Project 189 views
- Cape & Coast Bank Adds Trio of Executives 164 views
- Trial Court Offices Moving to Financial District 92 views
- High-Value AI Startup Leases Offices at One Lincoln 78 views
- Massachusetts Nearing 100 ‘Housing Choice’ Communities 58 views
- 163K SF Development Possible at Site of Cambridge Condos 57 views
- Is Boston Headed for Embarrassment Thanks to Warren’s Housing Bill? 48 views
- River Run Bancorp Promotes New CFO 40 views
- Riverview’s Demise Highlights Condo Hazards 26 views
- Massachusetts Is Demolishing Its Way Out of Workforce Housing 26 views